Clinical Trial Imaging Market to 2024: In-depth Market View, Key Product Categories & Technologies, Product Pipeline, Top Players & Company Share, Competitive Dynamics, End Market Mix, Technology Outlook, Growth Drivers & Restraints, Major Trends and Issues, Commercial & M&A Insights, Segment Forecast, Key Conclusions & Sector Outlook

$3,650.00$6,650.00

Clear
  • Report Description
  • Table of Content
  • Highlight
  • Research Methodology
  • Request Free Sample

Global Clinical Trial Imaging Market was valued at $730.1 Million in 2015 and is estimated to grow at a CAGR of over 6% from 2016 to 2024.

 

Snowballing geriatric population coupled with the growing incidences of chronic diseases are among the key factors driving the clinical trial imaging market growth over the coming years. Government initiatives paired with private investments and increasing research and development activities are expected to escalate market growth significantly over the next few years.

 

Medical imaging applications for pharmaceutical clinical trials comprise determining the responder patients, diagnosing and estimating lesions and their severity, observing therapy effects and their follow-ups, and identifying disease predisposition. Further, medical imaging can also play a vital role in product development process as it has the capability to diminish the late-stage attrition by collecting additional data in the pre-clinical trials of efficacy, safety, and mechanism of action.

 

Clinical Trial Imaging Market 2024

 

The flourishing biotechnology and pharmaceutical industry, and rise in the number of contract manufacturing organization is another factor driving market growth. However, high cost associated with machinery purchase and installation is anticipated to obstruct market growth. Additionally, the enormous cost of clinical trials may also hinder demand over the forecast period.

 

The rapid upsurge in demand for multimodal imaging systems paired with the growth potential presented by the emerging markets may also boost product demand. Growing emphasis on improved diagnoses along with widespread usage of medical imaging as a surrogate endpoint is expected to catapult growth over the next few years.

 

Extensive use across varied application areas including biotech companies, research centers, pharmaceutical and hospitals is increasingly driving the demand for clinical trial imaging. Additionally, portability and miniaturization of equipment are adding value to the clinical imaging market resulting in increasing product demand worldwide.

 

“Optimal Price Point (OPP) for Clinical Trial Imaging Products”

 

Estimated Average solution cost – $ xx globally. However, with growth in usage across varied application and increasing SMEs, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model.

 

“Clinical trial imaging to overcome the critical challenges associated with drug development process”

 

Use of imaging biomarkers and imaging surrogate endpoints offer quick results with improved statistical control as they help in facilitating small group sizes for drug efficacy studies. Clinical trial imaging is widely used in drug safety assessment throughout clinical trials in the absence of appropriate biomarker. With its pervasive applications, medical imaging is observing a rapid growth in its usage for clinical trials.

 

“Notable industry participants include PAREXEL International Corporation, VirtualScopics Inc. and Cardiovascular Imaging Technologies LLC”

 

Key players include Intrinsic Imaging LLC, BioClinica Inc, Biomedical Systems, ICON plc, Biotelemetry, WorldCare Clinical LLC, and IXICO PLC. Companies in this space focus on increasing their R&D investments to develop innovative and high-efficiency products in an attempt to outperform their competition.

 

Major industry players emphasize on the development of reducing product cost to penetrate into the market and acquire larger market share. In addition, large organizations actively strive for mergers and acquisitions to increase their market share and penetrate into new untapped markets.

 

“Technology outlook”

 

Advancements in diagnostic imaging technology have facilitated improved diagnosis by providing instant clinical information. Availability of prompt diagnostic data has subsequently helped reduce overall healthcare spending by replacing more expensive diagnostic exams.

The cost-effectiveness, efficacy, speed and noninvasive nature of ultrasound imaging are among the major attributes that have given this technology an advantage over other imaging modalities.

Chapter 1 Methodology and Scope

  • Research Methodology
  • Research Scope & Assumptions
  • List of Data Sources

Chapter 2 Executive Summary

Chapter 3 Clinical Trial Imaging Overview

  • Market Ecosystem
  • Key Stakeholders
  • Industry Trends & Analysis

Chapter 4 Clinical Trial Imaging Industry Outlook

  • Market Overview
  • Market Segmentation
  • Market Size & Growth Prospects
  • Market Analysis By Type
  • Market Analysis By Modality
  • Market Analysis By End-Use
  • Leading Brand Dynamics
  • Key Market Drivers
    • Increasing geriatric population
    • Growing incidences of chronic diseases
  • Key Market Challenges/ Restraints
    • High product cost
  • Key Market Opportunities
    • Emerging application areas particularly in untapped markets
  • Major Trends & Issues
  • Penetration & Growth Prospects
  • Industry Analysis - Porter’s
  • Clinical Trial Imaging Market-PESTEL Analysis
  • Technology Landscape

Chapter 5: Pipeline Intelligence

  • Executive Summary
  • Upcoming Products
  • Key R&D Trends
  • M&A Outlook

Chapter 6: Regional Market Outlook

Clinical Trial Imaging Market Landscape by Region- 2014

  • North America Market Landscape Analysis, 2014-2024 (USD Mn)
    • S. Market Landscape Analysis, 2014-2024
    • Canada Market Landscape Analysis-2014-2024
  • Europe Market Landscape Analysis, 2014-2024 (USD Mn)
    • K Market Landscape Analysis, 2014-2024
    • Germany Market Landscape Analysis, 2014-2024
    • France Market Landscape Analysis, 2014-2024
    • Italy Market Landscape Analysis, 2014-2024
    • Spain Market Landscape Analysis, 2014-2024
  • Latin America Market Landscape Analysis, 2014-2024 (USD Mn)
    • Brazil Market Landscape Analysis, 2014-2024
    • Mexico Market Landscape Analysis, 2014-2024
    • Colombia Market Landscape Analysis, 2014-2024
  • Asia Pacific Market Landscape Analysis, 2014-2024 (USD Mn)
    • Japan Market Landscape Analysis, 2014-2024
    • China Market Landscape Analysis, 2014-2024
    • India Market Landscape Analysis, 2014-2024
  • Middle East & Africa Market Landscape Analysis, 2014-2024 (USD Mn)
    • Saudi Arabia Market Landscape Analysis, 2014-2024
    • UAE Market Landscape Analysis, 2014-2024

Chapter 7: Pricing Analysis

Optimal Price Points (OPP), Indifference Price Points (IPP) and Range of Acceptable Prices (RAP) of leading brands and volume estimation by Region- 2015

  • North America Pricing Analysis (OPP, IPP, RAP - 2015)
    • S. Pricing Analysis-2015
    • Canada Pricing Analysis-2015
  • Europe Pricing Analysis (OPP, IPP, RAP - 2014)
    • K Pricing Analysis-2015
    • Germany Pricing Analysis-2015
    • France Pricing Analysis-2015
    • Italy Pricing Analysis-2015
    • Spain Pricing Analysis-2015
  • Latin America Pricing Analysis (OPP, IPP, RAP - 2015)
    • Brazil Pricing Analysis-2015
    • Mexico Pricing Analysis-2015
    • Colombia Pricing Analysis-2015
  • Asia Pacific Pricing Analysis (OPP, IPP, RAP - 2015)
    • Japan Pricing Analysis-2015
    • China Pricing Analysis-2015
    • India Pricing Analysis-2015
  • Middle East & Africa Pricing Analysis (OPP, IPP, RAP - 2015)
    • Saudi Arabia Pricing Analysis-2015
    • UAE Pricing Analysis-2015

Chapter 8: Technology Outlook

  • Executive Summary
  • Technology Evolution
  • Key R&D trends
  • Emerging Technology Analysis
  • Technology Crunch

Chapter 9: Competitive Landscape

  • BioClinica Inc
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Biomedical Systems
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Biotelemetry
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Cardiovascular Imaging Technologies LLC
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • ICON plc
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Intrinsic Imaging LLC
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • IXICO PLC
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • PAREXEL International Corporation
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • VirtualScopics Inc.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • WorldCare Clinical LLC
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
List of Tables  
  • TABLE 1 Clinical Trial Imaging Market - Industry Snapshot & Key Buying Criteria, 2014 - 2024
  • TABLE 2 Global Clinical Trial Imaging Market, 2014 – 2024 (USD Million)
  • TABLE 3 Global Clinical Trial Imaging Market by Type, 2014 – 2024 (USD Million)
  • TABLE 4 Global Clinical Trial Imaging Market by Modality, 2014 – 2024 (USD Million)
  • TABLE 5 Global Clinical Trial Imaging Market by End-Use, 2014 – 2024 (USD Million)
  • TABLE 6 Clinical Trial Imaging Market - Key Market Driver Analysis
  • TABLE 7 Clinical Trial Imaging Market - Key Market Restraint/ Challenge Analysis
  • TABLE 8 Clinical Trial Imaging Market – Key Opportunity Analysis
  • TABLE 9 North America Clinical Trial Imaging Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 10 U.S. Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 11 Canada Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 12 Europe Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 13 UK Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 14 Germany Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 15 France Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 16 Italy Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 17 Spain Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 18 Latin America Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 19 Brazil Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 20 Mexico Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 21 Colombia Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 22 Asia Pacific Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 23 Japan Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 24 China Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 25 India Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 26 Middle East & Africa Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 27 Saudi Arabia Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 28 UAE Clinical Trial Imaging Market Landscape Analysis, 2014-2024 (USD Million)
  • TABLE 29 North America Pricing Analysis
  • TABLE 30 North America Pricing Analysis (OPP, IPP, RAP - 2015)
  • TABLE 31 U.S. Pricing Analysis-2015
  • TABLE 32 Canada Pricing Analysis-2015
  • TABLE 33 Europe Pricing Analysis (OPP, IPP, RAP - 2015)
  • TABLE 34 UK Pricing Analysis-2015
  • TABLE 35 Germany Pricing Analysis-2015
  • TABLE 36 France Pricing Analysis-2015
  • TABLE 37 Italy Pricing Analysis-2015
  • TABLE 38 Spain Pricing Analysis-2015
  • TABLE 39 Latin America Pricing Analysis (OPP, IPP, RAP - 2015)
  • TABLE 40 Brazil Pricing Analysis-2015
  • TABLE 41 Mexico Pricing Analysis-2015
  • TABLE 42 Colombia Pricing Analysis-2015
  • TABLE 43 Asia Pacific Pricing Analysis (OPP, IPP, RAP - 2015)
  • TABLE 44 Japan Pricing Analysis-2015
  • TABLE 45 China Pricing Analysis-2015
  • TABLE 46 India Pricing Analysis-2015
  • TABLE 47 Middle East & Africa Pricing Analysis (OPP, IPP, RAP - 2015)
  • TABLE 48 Saudi Arabia Pricing Analysis-2015
  • TABLE 49 UAE Pricing Analysis-2015
List of Figures-
  • Clinical Trial Imaging Market Segmentation
  • Market Size & Growth Prospects
  • Leading Brand Dynamics
  • Penetration & Growth Prospects
  • Industry Analysis – Porter’s
  • Clinical Trial Imaging Market – PESTEL Analysis
  • Clinical Trial Imaging Market Share by Type, 2015 & 2024
  • Clinical Trial Imaging Market Share by Modality, 2015 & 2024
  • Clinical Trial Imaging Market Share by End-Use, 2015 & 2024
  • Clinical Trial Imaging Market Share by Region, 2015 & 2024

Key Insights Addressed:  

  • Defining market size from 2013 to 2015.
  • Estimating market growth till 2024 and consequence market forecast.
  • Identifying market drivers, restraints & future opportunities and allowing decision-maker with a range of possible outcomes and the probabilities that will occur for any choice of action.
  • Market segments and regions that will drive or lead market growth.
  • Defining Optimal Price Point (OPP) which will be accepted and recommended by maximum customers.
  • A bird’s-eye view of the competitive landscape and the key market players.
  • Key strategic growth driver adopted by market players. In-depth analysis of their strategies and implication on competition & growth.
  Key Findings:  
  • Global Clinical Trial Imaging Market was valued at $730.1 Million in 2015 and is estimated to grow at a CAGR of over 6% from 2016 to 2024.
  • Snowballing geriatric population coupled with the growing incidences of chronic diseases are among the key factors driving the clinical trial imaging market growth over the coming years.
  • The flourishing biotechnology and pharmaceutical industry, and rise in the number of contract manufacturing organization is another factor driving market growth.
  • The rapid upsurge in demand for multimodal imaging systems paired with the growth potential presented by the emerging markets may also boost product demand.
  • Key players include Intrinsic Imaging LLC, BioClinica Inc, Biomedical Systems, ICON plc, Biotelemetry, WorldCare Clinical LLC, and IXICO PLC. Companies in this space focus on increasing their R&D investments to develop innovative and high-efficiency products in an attempt to outperform their competition.

Ameri Research implies a unique methodology of published information and primary research to bring key insights to customer decision making process. Our analytics model helps us to understand the structured and unstructured information from various sources. Key steps involves in the process are as below-

    1. Analyzing Published Information- Access to large pool of paid and unpaid published information via different sources and analyzing market trend.
    2. Setting Foundation- Input from analysis of secondary sources set our foundation to market analysis and helps in setting the scope for further research. Setting the scope involves Ameri Research proprietary statistical model, discussion with industry leaders, internal brain storming, key discussion pointers from various forums etc.
    3. Need Gap Analysis- Defining the gap between our scope and availability of information.
    4. KOL Panel Discussion- Focused Group Discussion with a structured discussion guide to fine tune the gap and deriving the factors driving/restraining the market trend.
    5. Quantitative Research- Sampling large number of industry players, Education/Research Institutes, Government bodies, NGOs, Individual acclaimed researchers and conducting primary interview with a structured questionnaire.
    6. Data Triangulation- We applies bottom-up demand approach or top-down estimation or a combined approach to triangulate the data points.
    7. Analyst Comment- Each of our analyst carry large pool of experience from domain perspective and add their value which are directional in nature
global-aesthetic-dermatology-market

To request a free sample copy of this report, please complete the form below verified and secure

We offer complete free customization that addresses client’s need. This includes insights from primary market research and a 60-minute free analyst consultation post report purchase.

This website is secure and your personal details are safe. Privacy policy

Description

Global Clinical Trial Imaging Market was valued at $730.1 Million in 2015 and is estimated to grow at a CAGR of over 6% from 2016 to 2024.

 

Snowballing geriatric population coupled with the growing incidences of chronic diseases are among the key factors driving the clinical trial imaging market growth over the coming years. Government initiatives paired with private investments and increasing research and development activities are expected to escalate market growth significantly over the next few years.

 

Medical imaging applications for pharmaceutical clinical trials comprise determining the responder patients, diagnosing and estimating lesions and their severity, observing therapy effects and their follow-ups, and identifying disease predisposition. Further, medical imaging can also play a vital role in product development process as it has the capability to diminish the late-stage attrition by collecting additional data in the pre-clinical trials of efficacy, safety, and mechanism of action.

 

Clinical Trial Imaging Market 2024

 

The flourishing biotechnology and pharmaceutical industry, and rise in the number of contract manufacturing organization is another factor driving market growth. However, high cost associated with machinery purchase and installation is anticipated to obstruct market growth. Additionally, the enormous cost of clinical trials may also hinder demand over the forecast period.

 

The rapid upsurge in demand for multimodal imaging systems paired with the growth potential presented by the emerging markets may also boost product demand. Growing emphasis on improved diagnoses along with widespread usage of medical imaging as a surrogate endpoint is expected to catapult growth over the next few years.

 

Extensive use across varied application areas including biotech companies, research centers, pharmaceutical and hospitals is increasingly driving the demand for clinical trial imaging. Additionally, portability and miniaturization of equipment are adding value to the clinical imaging market resulting in increasing product demand worldwide.

 

“Optimal Price Point (OPP) for Clinical Trial Imaging Products”

 

Estimated Average solution cost – $ xx globally. However, with growth in usage across varied application and increasing SMEs, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model.

 

“Clinical trial imaging to overcome the critical challenges associated with drug development process”

 

Use of imaging biomarkers and imaging surrogate endpoints offer quick results with improved statistical control as they help in facilitating small group sizes for drug efficacy studies. Clinical trial imaging is widely used in drug safety assessment throughout clinical trials in the absence of appropriate biomarker. With its pervasive applications, medical imaging is observing a rapid growth in its usage for clinical trials.

 

“Notable industry participants include PAREXEL International Corporation, VirtualScopics Inc. and Cardiovascular Imaging Technologies LLC”

 

Key players include Intrinsic Imaging LLC, BioClinica Inc, Biomedical Systems, ICON plc, Biotelemetry, WorldCare Clinical LLC, and IXICO PLC. Companies in this space focus on increasing their R&D investments to develop innovative and high-efficiency products in an attempt to outperform their competition.

 

Major industry players emphasize on the development of reducing product cost to penetrate into the market and acquire larger market share. In addition, large organizations actively strive for mergers and acquisitions to increase their market share and penetrate into new untapped markets.

 

“Technology outlook”

 

Advancements in diagnostic imaging technology have facilitated improved diagnosis by providing instant clinical information. Availability of prompt diagnostic data has subsequently helped reduce overall healthcare spending by replacing more expensive diagnostic exams.

The cost-effectiveness, efficacy, speed and noninvasive nature of ultrasound imaging are among the major attributes that have given this technology an advantage over other imaging modalities.

Additional information

Price

Single User $3,650, Multiple User $4,650, Enterprise User $6,650